"The Mischer Neuroscience Institute is home to one of the largest group of neurosurgeons and neurologists in Central Houston"

During the past decade, Houston Neurology Clinical & Diagnostic Consultants conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Houston Neurology Clinical & Diagnostic Consultants" are "Migraine" (2 trials), "Chronic Migraine" (1 trials) and "Episodic Migraine" (1 trials). Many other conditions were trialed in "Houston Neurology Clinical & Diagnostic Consultants" in a lesser frequency.

Most popular intervention types in "Houston Neurology Clinical & Diagnostic Consultants" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Galcanezumab" (2 trials) and "Lasmiditan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Houston Neurology Clinical & Diagnostic Consultants" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Houston Neurology Clinical & Diagnostic Consultants". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Houston Neurology Clinical & Diagnostic Consultants, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Houston Neurology Clinical & Diagnostic Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".